IDENTIFICATION OF TARGETS FOR TCR-IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA USING A CLINICALLY RELEVANT PLATFORM

被引：0
|
作者：
Maravelia, P. [1 ]
Potti, A. Perez [1 ]
Silva, D. Nascimento [1 ]
Healy, K. [1 ]
Sekine, T. [1 ]
Chrobok, M. [1 ]
Jorns, C. [1 ]
Sallberg, M. [1 ]
Buggert, M. [1 ]
Pasetto, A. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
CYTOTHERAPY | 2021年 / 23卷 / 05期
关键词：
immunotherapy; hepatocellular carcinoma; T cell receptor;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
409
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [41] What are the most important predictive factors for clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma?
    Navarro, Jonathan Geograpo
    Yang, Seok Jeong
    Kang, Incheon
    Choi, Gi Hong
    Han, Dai Hoon
    Kim, Kyung Sik
    Choi, Jin Sub
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2020, 98 (02) : 62 - 71
  • [42] Identification of serum glycobiomarkers for Hepatocellular Carcinoma using lectin microarrays
    Zhang, Yue
    Zhang, Sihua
    Liu, Jianhua
    Zhang, Yunli
    Liu, Yanjie
    Shen, Shuang
    Tian, Fangfang
    Yan, Gaobo
    Gao, Yongqing
    Qin, Xiaosong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Identification of secretory pathway-related genes based on Random Forest algorithm to predict the prognosis and immunotherapy response of hepatocellular carcinoma
    Wang, Zanzhi
    Shi, Pengwei
    Huang, Peng
    Xu, Chun
    He, Yaoquan
    Lei, Wenxiong
    JOURNAL OF GENE MEDICINE, 2024, 26 (01)
  • [44] Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
    Yinan Hu
    Jingyi Liu
    Jiahao Yu
    Fangfang Yang
    Miao Zhang
    Yansheng Liu
    Shuoyi Ma
    Xia Zhou
    Jingbo Wang
    Ying Han
    Cancer Cell International, 22
  • [45] Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
    Yang, Li
    Zhang, Weigang
    Yan, Yifeng
    AGING-US, 2023, 15 (13): : 6135 - 6151
  • [46] Identification of ACSF gene family as therapeutic targets and immune-associated biomarkers in hepatocellular carcinoma
    Zhao, Zijin
    Liu, Miaomiao
    Xu, Zhijie
    Cai, Yuan
    Peng, Bi
    Liang, Qiuju
    Yan, Yuanliang
    Liu, Wei
    Kang, Fanhua
    He, Qingchun
    Hong, Qianhui
    Zhang, Wenqin
    Li, Jianbo
    Peng, Jinwu
    Zeng, Shuangshuang
    AGING-US, 2022, 14 (19): : 7926 - 7940
  • [47] Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification
    Hu, Bo
    Li, Hong
    Guo, Wei
    Sun, Yun-Fan
    Zhang, Xin
    Tang, Wei-Guo
    Yang, Liu-Xiao
    Xu, Yang
    Tang, Xiao-Yan
    Ding, Guo-Hui
    Qiu, Shuang-Jian
    Zhou, Jian
    Li, Yi-Xue
    Fan, Jia
    Yang, Xin-Rong
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (06) : 1606 - 1617
  • [48] Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
    Zhang, Zhengwei
    Zhang, Feng
    Pang, Ping
    Li, Yapeng
    Chen, Xiaoning
    Sun, Shibo
    Bian, Yu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [49] The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy
    Zou, Renrui
    Liu, Yaqian
    Qiu, Sangsang
    Lu, Ya
    Chen, Yan
    Yu, Hui
    Zhu, Hangju
    Zhu, Wenbo
    Zhu, Longbiao
    Feng, Jifeng
    Han, Jing
    CANCER BIOMARKERS, 2023, 38 (04) : 551 - 566
  • [50] Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
    Zheng, Susu
    Xie, Xiaoying
    Guo, Xinkun
    Wu, Yanfang
    Chen, Guobin
    Chen, Xiaochun
    Wang, Meixia
    Xue, Tongchun
    Zhang, Boheng
    FRONTIERS IN GENETICS, 2021, 12
12345